Interleukin-4 Receptor Targeting Peptide AP
Not For Human Use, Lab Use Only.
Cat.#: 318894
Special Price 78.00 USD
-
Product Name
Interleukin-4 Receptor Targeting Peptide AP
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
H-CRKRLDRNC-OH
-
Sequence
H-Cys-Arg-Lys-Arg-Leu-Asp-Arg-Asn-Cys-OH
-
Length (aa)
9
-
Peptide Purity (HPLC)
97.95%
-
Molecular Formula
C44H82N20O13S2
-
Molecular Weight
1163.37
-
Source
Synthetic
-
Form
Powder
-
Description
Atherosclerotic plaque (AP) homing nonapeptide (CRKRLDRNC) was identified after cycles of ex vivophage display screening on human atheroma tissue and further validated for its targeting capability to the atherosclerotic plaques in an in vivomurine model. A homology sequence search identified the AP binding sequence KRLDRN motif corresponding to Interleukin-4 (IL-4). Its receptor, IL-4R, is abundantly expressed by glioma cells, thereby presenting the CRKRLDRNC as a potential tool for glioma targeting. Park et al. reported promising results with the AP peptide conjugated to doxorubicin-containing microbubbles and nanoliposomes as a proof-of-concept for targeted imaging and intervention in glioma using the U87MG in vitromodels. AP peptide conjugated to doxorubicin-containing liposomes also demonstrated enhanced antitumor efficacy in an in vivomodel of human lung cancer.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
-
References
- Hong HY, Lee HY, Kwak W, Yoo J, Na MH, So IS, et al. Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis. J Cell Mol Med. 2008;12(5B):2003-14
-
About TFA salt
Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.
Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.
Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.
-
Molar Concentration Calculator
-
Dilution Calculator
-
Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"